The accelerated tumor development in old mice in this study is also consistent in part with our previous study with Tg(act-TXN)+/0 mice, in which end-of-life pathology of Tg(act-TXN)+/0 mice had a slightly higher incidence of fatal lymphoma compared to WT mice [20]. The gene discussed is TXN; the disease is lymphoma.